UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Protection against Malaria by MSP3 Candidate Vaccine

The New England journal of medicine, 2011-09, Vol.365 (11), p.1062-1064

2011

Volltextzugriff (PDF)

Worms can worsen malaria: towards a new means to roll back malaria?

Trends in parasitology, 2005-08, Vol.21 (8), p.359-362

2005

Volltextzugriff (PDF)

A phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Montanide® ISA 720

PloS one, 2011-09, Vol.6 (9), p.e24413

2011

Volltextzugriff (PDF)

Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3

PLoS medicine, 2007-11, Vol.4 (11), p.e320-e320

2007

Volltextzugriff (PDF)

High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure

BMC medicine, 2018-10, Vol.16 (1), p.181-181, Article 181

2018

Volltextzugriff (PDF)

Further improvements of the P. falciparum humanized mouse model

PloS one, 2011-03, Vol.6 (3), p.e18045-e18045

2011

Volltextzugriff (PDF)

Protective epitopes of the Plasmodium falciparum SERA5 malaria vaccine reside in intrinsically unstructured N-terminal repetitive sequences

PloS one, 2014-06, Vol.9 (6), p.e98460-e98460

2014

Volltextzugriff (PDF)

A Novel Antibody-Dependent Cellular Cytotoxicity Mechanism Involved in Defense against Malaria Requires Costimulation of Monocytes FcγRII and FcγRIII

Journal of Immunology, 2007-03, Vol.178 (5), p.3099-3106

2007

Volltextzugriff (PDF)

Evaluating Human Immune Responses for Vaccine Development in a Novel Human Spleen Cell-Engrafted NOD-SCID-IL2rγNull Mouse Model

Frontiers in immunology, 2018-03, Vol.9, p.601-601

2018

Volltextzugriff (PDF)

Pre-clinical assessment of novel multivalent MSP3 malaria vaccine constructs

PloS one, 2011-12, Vol.6 (12), p.e28165-e28165

2011

Volltextzugriff (PDF)

Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development

The Lancet infectious diseases, 2002-09, Vol.2 (9), p.564-573

2002

Volltextzugriff (PDF)

Phase I Malaria Vaccine Trial with a Long Synthetic Peptide Derived from the Merozoite Surface Protein 3 Antigen

Infection and Immunity, 2005-12, Vol.73 (12), p.8017-8026

2005

Volltextzugriff (PDF)

A conserved multi-gene family induces cross-reactive antibodies effective in defense against Plasmodium falciparum

PloS one, 2009-04, Vol.4 (4), p.e5410-e5410

2009

Volltextzugriff (PDF)

Association between Protection against Clinical Malaria and Antibodies to Merozoite Surface Antigens in an Area of Hyperendemicity in Myanmar: Complementarity between Responses to Merozoite Surface Protein 3 and the 220-Kilodalton Glutamate-Rich Protein

Infection and Immunity, 2004-01, Vol.72 (1), p.247-252

2004

Volltextzugriff (PDF)

Increase of malaria attacks among children presenting concomitant infection by Schistosoma mansoni in Senegal

Malaria journal, 2004-11, Vol.3 (1), p.43-43

2004

Volltextzugriff (PDF)

A multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens

Malaria journal, 2010-11, Vol.9 (1), p.317-317, Article 317

2010

Volltextzugriff (PDF)

Anti–MSP1 Block 2 Antibodies Are Effective at Parasite Killing in an Allele-Specific Manner by Monocyte-Mediated Antibody-Dependent Cellular Inhibition

The Journal of infectious diseases, 2009-04, Vol.199 (8), p.1151-1154

2009

Volltextzugriff (PDF)

Understanding human-Plasmodium falciparum immune interactions uncovers the immunological role of worms

PloS one, 2010-02, Vol.5 (2), p.e9309-e9309

2010

Volltextzugriff (PDF)

Improved Assessment of Plasmodium vivax Response to Antimalarial Drugs by a Colorimetric Double-Site Plasmodium Lactate Dehydrogenase Antigen Capture Enzyme-Linked Immunosorbent Assay

Antimicrobial Agents and Chemotherapy, 2007-06, Vol.51 (6), p.2112-2116

2007

Volltextzugriff (PDF)

A distinct peripheral blood monocyte phenotype is associated with parasite inhibitory activity in acute uncomplicated Plasmodium falciparum malaria

PLoS pathogens, 2009-10, Vol.5 (10), p.e1000631-e1000631

2009

Volltextzugriff (PDF)

The malaria candidate vaccine liver stage antigen-3 is highly conserved in Plasmodium falciparum isolates from diverse geographical areas

Malaria journal, 2009-10, Vol.8 (1), p.247-247, Article 247

2009

Volltextzugriff (PDF)

Long-Term Multiepitopic Cytotoxic-T-Lymphocyte Responses Induced in Chimpanzees by Combinations of Plasmodium falciparum Liver-Stage Peptides and Lipopeptides

Infection and Immunity, 2004-08, Vol.72 (8), p.4376-4384

2004

Volltextzugriff (PDF)

Update on the clinical development of candidate malaria vaccines

The American journal of tropical medicine and hygiene, 2004-08, Vol.71 (2 Suppl), p.239-247

2004

Volltextzugriff (PDF)

1 – 25 von 187

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(184)
Mit Volltextzugriff
(166)

Publikationsform

Artikel
(187)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Protection against Malaria by MSP3 Candidate Vaccine

Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study

The rise and fall of malaria in a west African rural community, Dielmo, Senegal, from 1990 to 2012: a 22 year longitudinal study

Worms can worsen malaria: towards a new means to roll back malaria?

A phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Montanide® ISA 720

Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3

High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure

Further improvements of the P. falciparum humanized mouse model

Protective epitopes of the Plasmodium falciparum SERA5 malaria vaccine reside in intrinsically unstructured N-terminal repetitive sequences

A Novel Antibody-Dependent Cellular Cytotoxicity Mechanism Involved in Defense against Malaria Requires Costimulation of Monocytes FcγRII and FcγRIII

Evaluating Human Immune Responses for Vaccine Development in a Novel Human Spleen Cell-Engrafted NOD-SCID-IL2rγNull Mouse Model

Pre-clinical assessment of novel multivalent MSP3 malaria vaccine constructs

Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development

Phase I Malaria Vaccine Trial with a Long Synthetic Peptide Derived from the Merozoite Surface Protein 3 Antigen

A conserved multi-gene family induces cross-reactive antibodies effective in defense against Plasmodium falciparum

Association between Protection against Clinical Malaria and Antibodies to Merozoite Surface Antigens in an Area of Hyperendemicity in Myanmar: Complementarity between Responses to Merozoite Surface Protein 3 and the 220-Kilodalton Glutamate-Rich Protein

Increase of malaria attacks among children presenting concomitant infection by Schistosoma mansoni in Senegal

A multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens

Anti–MSP1 Block 2 Antibodies Are Effective at Parasite Killing in an Allele-Specific Manner by Monocyte-Mediated Antibody-Dependent Cellular Inhibition

Understanding human-Plasmodium falciparum immune interactions uncovers the immunological role of worms

Improved Assessment of Plasmodium vivax Response to Antimalarial Drugs by a Colorimetric Double-Site Plasmodium Lactate Dehydrogenase Antigen Capture Enzyme-Linked Immunosorbent Assay

A distinct peripheral blood monocyte phenotype is associated with parasite inhibitory activity in acute uncomplicated Plasmodium falciparum malaria

The malaria candidate vaccine liver stage antigen-3 is highly conserved in Plasmodium falciparum isolates from diverse geographical areas

Long-Term Multiepitopic Cytotoxic-T-Lymphocyte Responses Induced in Chimpanzees by Combinations of Plasmodium falciparum Liver-Stage Peptides and Lipopeptides

Update on the clinical development of candidate malaria vaccines

Suchergebnisse filtern